0.334

3.47% 0.0112

Vyne Therapeutics Inc (VYNE)

Overview News Price History Financials Discussions Forecast Stock Split

Vyne Therapeutics Inc stock is traded at $0.334, with a volume of 1.47M. It is up +3.47% in the last 24 hours and down -70.18% over the past month. VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

Previous Close:

$0.3228

Open:

$0.3185

24h Volume:

1.47M

Relative Volume:

0.82

Market Cap:

$5.08M

Revenue:

$486.00K

Net Income/Loss:

$-28.43M

P/E Ratio:

-0.1185

EPS:

-2.8189

Net Cash Flow:

$-26.75M

1W Performance:

-4.79%

1M Performance:

-70.18%

6M Performance:

-87.81%

1Y Performance:

-82.23%

1-Day Range:

$0.3176

$0.335

1-Week Range:

$0.3176

$0.3649

52-Week Range:

$0.3176

$4.30

Vyne Therapeutics Inc Stock (VYNE) Company Profile

Name

Vyne Therapeutics Inc

Sector

Healthcare (1157)

Industry

Biotechnology (645)

Phone

800-775-7936

Address

685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

VYNE's Discussions on Twitter

Compare VYNE with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VYNE Vyne Therapeutics Inc	0.334	5.73M	486.00K	-28.43M	-26.75M	-2.8189
VRTX Vertex Pharmaceuticals Inc	395.12	99.96B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	589.48	60.83B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	454.38	59.89B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	660.00	40.47B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	313.67	37.96B	3.81B	-644.79M	-669.77M	-6.24

Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-31-25	Downgrade	BTIG Research	Buy → Neutral
Nov-18-24	Initiated	BTIG Research	Buy
Dec-06-21	Resumed	H.C. Wainwright	Buy

Vyne Therapeutics Inc Stock (VYNE) Latest News

Aug 20, 2025

Is VYNE Therapeutics Inc. stock entering bullish territory2025 Market Sentiment & Daily Price Action Insights - Newser

Aug 20, 2025

VYNE Therapeutics Inc. stock volume spike explained2025 Bull vs Bear & Daily Growth Stock Investment Tips - Newser

Aug 20, 2025

Will breakout in VYNE Therapeutics Inc. lead to full recoveryJuly 2025 Analyst Calls & Daily Profit Maximizing Trade Tips - Newser

Aug 20, 2025

Why VYNE Therapeutics Inc. is moving todayJuly 2025 Setups & Risk Managed Investment Signals - Newser

Aug 20, 2025

What to do if you’re stuck in VYNE Therapeutics Inc.Quarterly Trade Review & Risk Controlled Daily Plans - Newser

Aug 20, 2025

Is it time to cut losses on VYNE Therapeutics Inc.July 2025 Gainers & Low Drawdown Investment Strategies - Newser

Aug 20, 2025

Aug 19, 2025

Price action breakdown for VYNE Therapeutics Inc.Volume Spike & AI Driven Price Forecasts - Newser

Aug 19, 2025

What MACD and RSI say about VYNE Therapeutics Inc.2025 Biggest Moves & Short-Term Trading Alerts - Newser

Aug 19, 2025

Will VYNE Therapeutics Inc. stock recover after recent drop2025 Market WrapUp & Daily Price Action Insights - Newser

Aug 19, 2025

Technical analysis overview for VYNE Therapeutics Inc. stockTrade Volume Report & Capital Efficiency Focused Strategies - Newser

Aug 19, 2025

Aug 18, 2025

VYNE Therapeutics Inc. Approaches Psychological Resistance Level2025 Major Catalysts & Weekly Consistent Profit Watchlists - newsimpact.co.kr

Aug 18, 2025

VYNE Therapeutics Q2 2025 Earnings: EPS Beats, Revenue Falls Short of Expectations - AInvest

Aug 18, 2025

VYNE Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Aug 18, 2025

Elliott Wave Theory Predicts Pullback in VYNE Therapeutics Inc.Buy Signal & Accurate Trade Setup Notifications - newsyoung.net

Aug 18, 2025

Aug 17, 2025

Chart based exit strategy for VYNE Therapeutics Inc.Swing Trade & Smart Investment Allocation Tips - Newser

Aug 17, 2025

Is VYNE Therapeutics Inc. reversing from oversold territoryQuarterly Investment Review & Daily Oversold Bounce Ideas - Newser

Aug 17, 2025

Does VYNE Therapeutics Inc. show high probability of reboundJuly 2025 Setups & Entry Point Confirmation Signals - Newser

Aug 17, 2025

Tools to assess VYNE Therapeutics Inc.’s risk profileJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - Newser

Aug 17, 2025

Aug 16, 2025

How to read the order book for VYNE Therapeutics Inc.2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - Newser

Aug 16, 2025

Is VYNE Therapeutics Inc. trending in predictive chart modelsMarket Trend Report & Growth Focused Entry Reports - Newser

Aug 16, 2025

Is VYNE Therapeutics Inc. stock technically oversold2025 Momentum Check & Low Volatility Stock Recommendations - mustnews.co.kr

Aug 16, 2025

Is VYNE Therapeutics Inc. stock poised for growth2025 Trade Ideas & Fast Gain Swing Alerts - Newser

Aug 16, 2025

How Resilient Is VYNE Therapeutics Inc. Stock During Economic DownturnsTake Profit & Fast Entry High Yield Tips - Newser

Aug 16, 2025

VYNE Therapeutics Inc. (NASDAQ:VYNE) Short Interest Up 526.7% in July - Defense World

Aug 16, 2025

Aug 15, 2025

Risk vs reward if holding onto VYNE Therapeutics Inc.Market Weekly Review & Daily Volume Surge Signals - Newser

Aug 15, 2025